Kelli Gosch
Women's Health · Branson, MONPI 1558496414
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 26.7% of the total.
Across 66 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$331
- Organon$186
- Novo Nordisk$117
- Astellas Pharma US Inc$107
- Pfizer$80
- Hologic Sales And Service, LLC$71
- plus $351 from 14 others
What the payments were for
- Food & beverage$1,243100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $331 |
| Organon | 10 | $186 |
| Novo Nordisk | 5 | $117 |
| Astellas Pharma US Inc | 5 | $107 |
| Pfizer | 4 | $80 |
| Hologic Sales And Service, LLC | 3 | $71 |
| Myriad Women's Health, Inc. | 1 | $56 |
| Exeltis, USA Inc. | 3 | $51 |
| Pacira Pharmaceuticals Incorporated | 1 | $35 |
| Medtronic | 1 | $30 |
| Bayer | 2 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $23 |
| Mayne Pharma Commercial LLC | 1 | $19 |
| Scynexis, Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $16 |
| BD | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| Davol Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Minerva Surgical, Inc | 1 | $13 |
How this compares
$1,243 in reported general payments places this provider in the 70th percentile of 208 women's health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 50 | $1,286 |
| Terconazole | 29 | $650 |
| Halobetasol Propionate | 13 | $606 |
| Oxybutynin Chloride ErOxybutynin Chloride | 42 | $480 |
| Medroxyprogesterone Acetate | 20 | $437 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $324 |
| ValacyclovirValacyclovir Hcl | 13 | $321 |
| ProgesteroneProgesterone, Micronized | 11 | $156 |
Paid to pharmacies, not to this prescriber.
Other women's health in Branson
- Kathryn SimoneBlue Springs$192K
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Karla WilmotIndependence$22K
- Janice EislebenSaint Louis$16K
- Susan Mitchell-DerenskiSaint Louis$14K
- Amanda SchillySaint Louis$8K
- Jeanette ShanholtzerLees Summit$7K
- Kris ScalfSaint Louis$7K
- Savannah HayesSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.